Matisse Capital Tekla Life Sciences Investors Transaction History

Matisse Capital

$205 Million
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 30, 2024	BUY	$13.38 - $14.33 $325,575 - $348,691	24,333 Added 243.33%	34,333 $467,000
Q4 2023 Feb 08, 2024	BUY	$11.35 - $13.6 $113,500 - $136,000	10,000 New	10,000 $134,000
Q3 2021 Nov 08, 2021	SELL	$20.27 - $22.67 $3.34 Million - $3.74 Million	-165,000 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$19.14 - $21.44 $2.95 Million - $3.31 Million	-154,311 Reduced 48.33%	165,000 $3.54 Million
Q3 2020 Nov 04, 2020	SELL	$16.71 - $19.06 $49,411 - $56,360	-2,957 Reduced 0.92%	319,311 $5.61 Million
Q2 2020 Jul 28, 2020	BUY	$14.22 - $18.38 $1.82 Million - $2.36 Million	128,237 Added 66.09%	322,268 $5.79 Million
Q1 2020 May 07, 2020	BUY	$12.22 - $17.99 $2.37 Million - $3.49 Million	194,031 New	194,031 $2.91 Million

Others Institutions Holding HQL

# of Institutions

75

Shares Held

9.29M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$47.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.7 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.75 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.46 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.75 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matisse Capital, based on Form 13F filings with the SEC.

News

Stay updated on Matisse Capital with notifications on news.